Skip to main content
Mantapex
Will the FDA approve retatrutide?
retatrutide (LY3437943)Science
Kalshi Active 5 markets·96¢ When will the FDA approve retatrutide (LY3437943)?·$0 Total Volume·-- Liquidity·-- OI
6mo·Jan 8, 2027

Track your prediction positions

Connect your Kalshi account to track your contracts, P&L, and settlements.

Wide spread
No chart data available

Markets

5
When (LY3437943)
$0 vol
96% ▲0.0%
When (LY3437943)
$0 vol
91% ▲0.0%
When (LY3437943)
$0 vol
89% ▲7.0%
When (LY3437943)
$0 vol
68% ▲0.0%
When (LY3437943)
$0 vol
16% ▼6.0%
When (LY3437943)
No order book data available

If the FDA approves retatrutide (LY3437943) for marketing before Jan 1, 2027, then the market resolves to Yes.

Series

KXFDARETATRUTIDE
View Full Series

Track Your Bets on Kalshi — and Everything Else

Create a free portfolio starting with your Kalshi positions, P&L & live odds. Then add crypto wallets, exchanges, DeFi & more — all in one place.

Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% free· Read-only· Encrypted